2017 National Drug Threat Survey
U.S. Department of Justice
Drug Enforcement Administration
Attn: Heather Spiegel, Project Manager
E-mail: [email protected]
8701 Morrissette Drive Springfield, VA 22152
Phone: (202) 353-1235 Fax: (202) 307-8955
General Instructions
Your response to this survey is vital to enhancing the collective understanding of the drug situation during the past year in your
jurisdiction and across the country. Your voluntary input, when combined with similar data collected nationwide, will be invaluable
in preparing the annual National Drug Threat Assessment, periodic regional drug threat assessments, and other strategic drugrelated intelligence reports.
The 2017 National Drug Threat Survey form is a PDF file that can be filled out, saved, and emailed to DEA. Please fill out the
survey as thoroughly as possible by clicking on the appropriate response for each question. If you have any questions related to
this survey or need assistance in completing your response, please contact DEA at (202) 353-1235. The deadline for responding
is November 15, 2016.
You may wish to print a paper copy of your responses before returning your completed survey to DEA.
Paperwork Reduction Act Notice - A person is not required to respond to a collection of information unless it displays a valid OMB
control number. We try to create instructions and forms that are accurate and easily understood and that impose the least
possible burden. The estimated average time to complete the form is 15 minutes. If you have any comments regarding the
accuracy of this estimate or suggestions for making this form simpler, please contact the Drug Enforcement Administration,
Domestic Strategic Intelligence Unit, at (202) 353-1235 or [email protected].
Please Provide The Following:
*Law Enforcement Agency:
Title (of person completing survey):
*First Name:
MI:
*Last Name:
Work Address :
City:
State :
Zip:
Work Phone :
Fax:
Work E‐mail Address:
Greatest Drug Threat, Drug-Related Crime, and Law Enforcement Resources
*1. For your jurisdiction, please indicate the drug that poses the greatest threat, the drug that
most contributes to violent crime, the drug that most contributes to property crime, and the drug
that takes up the most law enforcement resources.
Controlled
New
Cocaine
Prescription
Psychoactive
(Powder
Drugs
Fentanyl
Heroin
Marijuana Methamphetamine Substances*
Not
applicable Don't know
Greatest
Drug Threat
Violent
Crime
Property
Crime
Law
Enforcement
Resources
Drug Trafficking Attribute
2. Over the past year, has your agency experienced a significant change in a drug trafficking
attribute (availability, demand, distribution, production, transportation) for any of the drugs listed?
If so, please choose whether the change is an INCREASE (Inc), a DECREASE (Dec), or has REMAINED
THE SAME (Same) for each drug and each attribute. Choose NA for not applicable.
Availability
Inc
De
Inc
Dec
Inc
Dec
Same
N/A
Same
N/A
Same
N/A
Cocaine (Powder, Crack)
Controlled Prescription
Drugs
Fentanyl
Hallucinogens (LSD, PCP,
etc)
Heroin
Marijuana
MDMA
Methamphetamine
New Psychoactive
Substances*
Demand
Cocaine (Powder, Crack)
Controlled Prescription
Drugs
Fentanyl
Hallucinogens (LSD, PCP,
etc)
Heroin
Marijuana
MDMA
Methamphetamine
New Psychoactive
Substances*
Distribution
Cocaine (Powder, Crack)
Controlled Prescription
Drugs
Fentanyl
Hallucinogens (LSD, PCP,
etc)
Heroin
Marijuana
MDMA
Methamphetamine
New Psychoactive
Substances*
Drug Availability
3. Indicate the level of availability of the following drugs in your jurisdiction using the following
definitions:
High availability ‐ drug is easily obtained at any time;
Moderate availability ‐ drug is easily obtained most of the time;
Low availability ‐ drug is difficult to obtain most of the time.
High
Moderate
Low
Not Available
Don't Know
Cocaine (Powder, Crack)
Controlled Prescription
Drugs
Fentanyl
Hallucinogens (LSD, PCP,
etc)
Heroin
Marijuana
MDMA
Methamphetamine
New Psychoactive
Substances*
*New Psychoactive Substances includes Synthetic Cathinones (Bath Salts), Synthetic Cannabinoids (Spice, K2),
Phenethylamines (N-BOMe), or Research Chemicals (W-18,.U-47700).
Transportation
Inc
Cocaine (Powder, Crack)
Controlled Prescription
Drugs
Fentanyl
Hallucinogens (LSD, PCP,
etc)
Heroin
Marijuana
MDMA
Methamphetamine
New Psychoactive
Substances*
Dec
Same
N/A
Drug Production
4. Please indicate the level of the methamphetamine production problem in your jurisdiction using
the following definitions:
High production ‐ methamphetamine is frequently produced in your area;
Moderate production ‐ methamphetamine is sometimes produced in your area;
Low production ‐ methamphetamine is rarely produced in your area.
High Production
Moderate Production
Low Production
Not Produced
Don't Know
5. Please indicate how illegal cannabis (not including state‐approved) is cultivated in your
jurisdiction. (Check ALL that apply.)
Indoors (Residences
Outdoors (Not covered and located on public or private land)
Not Cultivated
Don't Know
6. Please indicate the production source of the majority of the marijuana seized in your
jurisdiction?
Domestic Produced ‐ United States
Foreign Produced ‐ Mexico
Foreign Produced ‐ Canada
Foreign Produced ‐ Caribbean
Don't Know
Not Applicable
State-Approved Marijuana Laws
7. How have state‐approved marijuana laws affected your jurisdiction over the past year
Increased criminal activity linked to marijuana
Decrease in criminal activity linked to marijuana
No change in criminal activity linked to marijuana
7a. What types of criminal activity have increased the past year linked to marijuana in your
jurisdiction? (Check ALL that apply.)
Increase in illegal cannabis grows in your jurisdiction
Increase in marijuana trafficked from states with approved medical or personal use (recreational) marijuana
Increase in Driving Under the Influence of Drugs (DUIDs) associated with marijuana use
Increase in home invasions/robberies associated with marijuana
Increase in cannabinoid extraction laboratories (BHO labs
None of the above represent the types of increased criminal activity
Not Applicable
Diversion/Illicit Use of Controlled Prescription Drugs
8. Please indicate the levels of diversion (e.g. doctor shopping, fraud, forgery) and illicit use for
the following types of controlled prescription drugs in your jurisdiction using the following
definitions:
High diversion/illicit use ‐ drugs are frequently diverted/used illicitly in your area;
Moderate diversion/illicit use ‐ drugs are sometimes diverted/used illicitly in your area;
Low diversion/illicit use ‐ drugs are rarely diverted/used illicitly in your area.
Level of Diversion
High
Moderate
Low
None
Don't Know
Narcotics (e.g.,
Vicodin®, OxyContin®)
Depressants (e.g.,
Valium®, Xanax®)
Stimulants (e.g.,
Adderall®, Ritalin®)
Steroids (e.g., Anadrol®,
Oxandrin®)
Level of Illicit Use
High
Narcotics (e.g.,
Vicodin®, OxyContin®)
Depressants (e.g.,
Valium®, Xanax®)
Stimulants (e.g.,
Adderall®, Ritalin®)
Steroids (e.g., Anadrol®,
Oxandrin®)
Moderate
Low
None
Don't Know
Thanks for your participation!